NO20003591L - Fettsyreanaloger for behandling av kreft - Google Patents

Fettsyreanaloger for behandling av kreft

Info

Publication number
NO20003591L
NO20003591L NO20003591A NO20003591A NO20003591L NO 20003591 L NO20003591 L NO 20003591L NO 20003591 A NO20003591 A NO 20003591A NO 20003591 A NO20003591 A NO 20003591A NO 20003591 L NO20003591 L NO 20003591L
Authority
NO
Norway
Prior art keywords
sub
alkyl
fatty acid
treatment
cancer
Prior art date
Application number
NO20003591A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003591D0 (no
Inventor
Rolf Berge
Original Assignee
Thia Medica As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica As filed Critical Thia Medica As
Priority to NO20003591A priority Critical patent/NO20003591L/no
Publication of NO20003591D0 publication Critical patent/NO20003591D0/no
Priority to BR0112399-8A priority patent/BR0112399A/pt
Priority to ES01952065T priority patent/ES2261441T3/es
Priority to PCT/NO2001/000301 priority patent/WO2002003983A1/en
Priority to AU2001272860A priority patent/AU2001272860B2/en
Priority to KR1020037000477A priority patent/KR100861428B1/ko
Priority to AU7286001A priority patent/AU7286001A/xx
Priority to RU2002134754/15A priority patent/RU2283105C2/ru
Priority to NZ523316A priority patent/NZ523316A/en
Priority to JP2002508437A priority patent/JP2004502732A/ja
Priority to CNB018127177A priority patent/CN100569228C/zh
Priority to AT01952065T priority patent/ATE320802T1/de
Priority to MXPA02012944A priority patent/MXPA02012944A/es
Priority to CA002414480A priority patent/CA2414480A1/en
Priority to EP01952065A priority patent/EP1313463B1/de
Priority to DE60118198T priority patent/DE60118198T2/de
Priority to KR1020087014318A priority patent/KR20080071598A/ko
Priority to US10/312,901 priority patent/US7378443B2/en
Publication of NO20003591L publication Critical patent/NO20003591L/no
Priority to ZA200210028A priority patent/ZA200210028B/en
Priority to NO20025930A priority patent/NO324634B1/no
Priority to HK04100292.1A priority patent/HK1057473A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20003591A 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft NO20003591L (no)

Priority Applications (21)

Application Number Priority Date Filing Date Title
NO20003591A NO20003591L (no) 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft
US10/312,901 US7378443B2 (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer
CNB018127177A CN100569228C (zh) 2000-07-13 2001-07-13 用于治疗癌症的脂肪酸类似物
MXPA02012944A MXPA02012944A (es) 2000-07-13 2001-07-13 Analogos de acido graso para el tratamiento de cancer.
PCT/NO2001/000301 WO2002003983A1 (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer
AU2001272860A AU2001272860B2 (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer
KR1020037000477A KR100861428B1 (ko) 2000-07-13 2001-07-13 암 치료용 지방산 유사체
AU7286001A AU7286001A (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer
RU2002134754/15A RU2283105C2 (ru) 2000-07-13 2001-07-13 Аналоги жирных кислот для лечения рака
NZ523316A NZ523316A (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer
JP2002508437A JP2004502732A (ja) 2000-07-13 2001-07-13 癌治療のための脂肪酸類似体
BR0112399-8A BR0112399A (pt) 2000-07-13 2001-07-13 Análogos de ácido graxo para o tratamento de câncer
AT01952065T ATE320802T1 (de) 2000-07-13 2001-07-13 Fettsäure-analoge zur behandlung von krebs
ES01952065T ES2261441T3 (es) 2000-07-13 2001-07-13 Analogos de acidos grasos para el tratamiento del cancer.
CA002414480A CA2414480A1 (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer
EP01952065A EP1313463B1 (de) 2000-07-13 2001-07-13 Fettsäure-analoge zur behandlung von krebs
DE60118198T DE60118198T2 (de) 2000-07-13 2001-07-13 Fettsäure-analoge zur behandlung von krebs
KR1020087014318A KR20080071598A (ko) 2000-07-13 2001-07-13 암 치료용 지방산 유사체
NO20025930A NO324634B1 (no) 2000-07-13 2002-12-11 Fettsyreanaloger for behandling av cancer
ZA200210028A ZA200210028B (en) 2000-07-13 2002-12-11 Fatty acid analogues for the treatment of cancer.
HK04100292.1A HK1057473A1 (en) 2000-07-13 2004-01-15 Fatty acid analogues for the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20003591A NO20003591L (no) 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft

Publications (2)

Publication Number Publication Date
NO20003591D0 NO20003591D0 (no) 2000-07-13
NO20003591L true NO20003591L (no) 2002-01-14

Family

ID=19911376

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20003591A NO20003591L (no) 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft
NO20025930A NO324634B1 (no) 2000-07-13 2002-12-11 Fettsyreanaloger for behandling av cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20025930A NO324634B1 (no) 2000-07-13 2002-12-11 Fettsyreanaloger for behandling av cancer

Country Status (18)

Country Link
US (1) US7378443B2 (de)
EP (1) EP1313463B1 (de)
JP (1) JP2004502732A (de)
KR (2) KR100861428B1 (de)
CN (1) CN100569228C (de)
AT (1) ATE320802T1 (de)
AU (2) AU7286001A (de)
BR (1) BR0112399A (de)
CA (1) CA2414480A1 (de)
DE (1) DE60118198T2 (de)
ES (1) ES2261441T3 (de)
HK (1) HK1057473A1 (de)
MX (1) MXPA02012944A (de)
NO (2) NO20003591L (de)
NZ (1) NZ523316A (de)
RU (1) RU2283105C2 (de)
WO (1) WO2002003983A1 (de)
ZA (1) ZA200210028B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
CN100351259C (zh) 2002-06-20 2007-11-28 Icvec有限公司 含硫的磷脂衍生物
EP1784223A2 (de) 2004-07-19 2007-05-16 Thia Medica AS Zusammensetzung enthaltend pflanzen- oder fischöl und nicht-oxidierbaren fettsäuren
NO20053519L (no) * 2005-07-18 2007-01-19 Thia Medica As Anvendelse av forbindelser som omfatter fettsyrer
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
EP2334234A4 (de) 2008-09-19 2013-03-20 Tandem Diabetes Care Inc Vorrichtung zur messung der konzentration eines gelösten stoffs und entsprechende verfahren
US20110152770A1 (en) 2009-07-30 2011-06-23 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
CA2904898C (en) 2013-03-11 2019-10-15 Jan Remmereit Lipid compositions containing bioactive fatty acids
AU2014229506B2 (en) 2013-03-11 2017-04-13 Nobesita As Natural lipids containing non-oxidizable fatty acids
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
DE102014116958B9 (de) * 2014-11-19 2017-10-05 Trumpf Laser- Und Systemtechnik Gmbh Optisches System zur Strahlformung eines Laserstrahls, Laserbearbeitungsanlage, Verfahren zur Materialbearbeitung und Verwenden einer gemeinsamen langgezogenen Fokuszone zur Lasermaterialbearbeitung
EP3307329A4 (de) * 2015-06-11 2019-05-15 University of Miami Krebsbehandlung und -diagnose
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用
CN107235880B (zh) * 2017-06-30 2018-10-30 江南大学 一种含硒阳离子表面活性剂及其应用
GB201910644D0 (en) * 2019-07-25 2019-09-11 Coegin Pharma As Cancer Treatment
US11897888B1 (en) 2020-04-30 2024-02-13 Stinginn Llc Small molecular inhibitors of sting signaling compositions and methods of use
CN115260964A (zh) * 2022-08-29 2022-11-01 烟台市福山义昌精细化工厂 一种石油油管丝扣专用密封胶及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686377B2 (ja) * 1985-09-30 1994-11-02 日清製粉株式会社 がん転移抑制剤
JPH0797320A (ja) * 1993-08-04 1995-04-11 Takuma Sasaki 制癌剤
US6358915B1 (en) * 1995-03-07 2002-03-19 George Washington University Methods for inhibiting metastasis
US5750515A (en) * 1995-04-10 1998-05-12 Taiho Pharmaceutical Co., Ltd. Cancer metastasis inhibitor
NO952796D0 (no) * 1995-07-14 1995-07-14 Rolf Berge Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
AU7240398A (en) * 1998-05-08 1999-11-29 Rolf Berge Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions
JP4993878B2 (ja) * 2005-06-28 2012-08-08 ダイキョーニシカワ株式会社 多気筒エンジンの吸気装置

Also Published As

Publication number Publication date
DE60118198D1 (de) 2006-05-11
BR0112399A (pt) 2003-05-27
NO20003591D0 (no) 2000-07-13
NO20025930D0 (no) 2002-12-11
MXPA02012944A (es) 2004-05-17
ATE320802T1 (de) 2006-04-15
CN1441671A (zh) 2003-09-10
CA2414480A1 (en) 2002-01-17
CN100569228C (zh) 2009-12-16
HK1057473A1 (en) 2004-04-08
WO2002003983A1 (en) 2002-01-17
DE60118198T2 (de) 2007-01-25
EP1313463A1 (de) 2003-05-28
ZA200210028B (en) 2004-01-26
RU2283105C2 (ru) 2006-09-10
KR20030016399A (ko) 2003-02-26
JP2004502732A (ja) 2004-01-29
US20040024063A1 (en) 2004-02-05
KR100861428B1 (ko) 2008-10-02
KR20080071598A (ko) 2008-08-04
US7378443B2 (en) 2008-05-27
AU7286001A (en) 2002-01-21
AU2001272860B2 (en) 2005-11-24
ES2261441T3 (es) 2006-11-16
NO20025930L (no) 2003-01-13
EP1313463B1 (de) 2006-03-22
NO324634B1 (no) 2007-11-26
NZ523316A (en) 2004-09-24

Similar Documents

Publication Publication Date Title
NO20003591D0 (no) Fettsyre analoger for behandling av kreft
MX9804105A (es) Antagonistas de taquicininas a base de piperidonas.
DK1485359T3 (da) Natriumkanalblokkere
DK1075260T3 (da) Hidtil ukendte fedtsyreanaloger til behandling af sekundær restenose
DE69918087D1 (de) Topische formulierungen zur behandlung von nagel pilzerkrankungen
BRPI0518068A (pt) composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada
KR960705810A (ko) 퀴나졸린 유도체(quinazoline derivatives)
RU2002134754A (ru) Аналоги жирных кислот для лечения рака
MY141869A (en) Mouth rinse compositions
NO20004844D0 (no) Fettsyre analoger for behandling av proliferative hudsykdommer
JP2004502732A5 (de)
EE200000472A (et) Kasvajavastased toimeained
DE69839781D1 (en) Heterocyclische topoisomerase toxine
CA2458318A1 (en) Wortmannin analogs and methods of using same
MY129176A (en) Tetrahydro gamma-carbolines
WO2004080408A3 (en) Method of treating cancer with azaspirane compositions
TR199802297T2 (xx) Eritromisin t�revlerinin 10-metil radikallerinin izomerizasyonu i�in yeni y�ntem.
NO20022977D0 (no) Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter
NO20023041D0 (no) Fremgangsmåte for fremstilling av pyrazolopyridazinderivater
EP0815111A4 (de) Analoge von n-acetylardeemin, verfahren zur herstellung und verwendung dieser analogen
TR200100070A2 (tr) Bileşim
KR950008515A (ko) 피리도[1,2,3-d,e][1,3,4] 벤족사디아진 유도체
HUP0301561A2 (hu) Triazintrion-szulfoxidok alkalmazása kokcidiózis elleni készítmények elżállítására
ATE105565T1 (de) Pradimicinderivate.
JPS5622732A (en) Antitumor agent composed mainly of organic silicon compound

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application